United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Novartis aims to strengthen cell therapy capabilities with CellforCure acquisition Novartis has announced plans to acquire CellforCure, a French contract development and manufacturing organisation (CDMO), from LFB for… bypharmanewsdailyDecember 23, 2018